# Clustering Approach 3 : METHLYATION_CNMF
Index	Clinical feature name	Test type	P value	Comment
1	Time to Death	logrank test	0.0263769577260511	Range of duration = 0.39 to 122.43, nDeath = 52, nCensor = 77
2	AGE	ANOVA	0.594547131354075	Range of values = 39 to 84, Mean = 66.4812, StdDev = 8.28343
3	GENDER	Fisher's exact test	0.107981281830743	nTypes = 2 (FEMALE/MALE), nPatients = 99/34
4	KARNOFSKY.PERFORMANCE.SCORE	ANOVA	0.191976581711292	Range of values = 0 to 100, Mean = 24.5455, StdDev = 38.3874, nMissing = 111
5	HISTOLOGICAL.TYPE	Chi-square test	0.308831846349547	nTypes = 3 (LUNG BASALOID SQUAMOUS CELL CARCINOMA/LUNG PAPILLARY SQUAMOUS CELL CARICNOMA/LUNG SQUAMOUS CELL CARCINOMA- NOT OTHERWISE SPECIFIED (NOS)), nPatients = 3/1/129
6	PATHOLOGY.T	Chi-square test	0.223773583253608	nTypes = 4 (T1/T2/T3/T4), nPatients = 24/87/11/11
7	PATHOLOGY.N	Chi-square test	0.0712491909584554	nTypes = 4 (N0/N1/N2/N3), nPatients = 84/34/10/5
8	PATHOLOGICSPREAD(M)	Fisher's exact test	0.121972852957334	nTypes = 2 (M0/M1), nPatients = 126/3, nMissing = 4
9	RADIATIONS.RADIATION.REGIMENINDICATION	Fisher's exact test	0.210526315789479	nTypes = 2 (NO/YES), nPatients = 132/1
10	NEOADJUVANT.THERAPY	Fisher's exact test	0.756139683183224	nTypes = 2 (NO/YES), nPatients = 121/12
